Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

miR-142 controls metabolic reprogramming that regulates dendritic cell activation.

Sun Y, Oravecz-Wilson K, Bridges S, McEachin R, Wu J, Kim SH, Taylor A, Zajac C, Fujiwara H, Peltier DC, Saunders T, Reddy P.

J Clin Invest. 2019 Apr 8;130:2029-2042. doi: 10.1172/JCI123839. eCollection 2019 Apr 8.

2.

High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells.

Malinarich F, Duan K, Hamid RA, Bijin A, Lin WX, Poidinger M, Fairhurst AM, Connolly JE.

J Immunol. 2015 Jun 1;194(11):5174-86. doi: 10.4049/jimmunol.1303316. Epub 2015 Apr 27.

3.

Nrf2-mediated metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia.

Wei HJ, Gupta A, Kao WM, Almudallal O, Letterio JJ, Pareek TK.

J Autoimmun. 2018 Nov;94:33-44. doi: 10.1016/j.jaut.2018.07.005. Epub 2018 Jul 17.

PMID:
30025621
4.

SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.

Du W, Amarachintha S, Wilson AF, Pang Q.

Stem Cells. 2016 Apr;34(4):960-71. doi: 10.1002/stem.2260. Epub 2015 Dec 31.

5.

Metabolic reprogramming in macrophages and dendritic cells in innate immunity.

Kelly B, O'Neill LA.

Cell Res. 2015 Jul;25(7):771-84. doi: 10.1038/cr.2015.68. Epub 2015 Jun 5. Review.

6.

Metabolism Is Central to Tolerogenic Dendritic Cell Function.

Sim WJ, Ahl PJ, Connolly JE.

Mediators Inflamm. 2016;2016:2636701. doi: 10.1155/2016/2636701. Epub 2016 Feb 11. Review.

7.

Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State.

Bros M, Youns M, Kollek V, Buchmüller D, Bollmann F, Seo EJ, Schupp J, Montermann E, Usanova S, Kleinert H, Efferth T, Reske-Kunz AB.

Front Pharmacol. 2018 Aug 17;9:915. doi: 10.3389/fphar.2018.00915. eCollection 2018.

8.

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.

Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA.

Nat Commun. 2015 Mar 26;6:6692. doi: 10.1038/ncomms7692.

9.

De Novo Fatty Acid Synthesis During Mycobacterial Infection Is a Prerequisite for the Function of Highly Proliferative T Cells, But Not for Dendritic Cells or Macrophages.

Stüve P, Minarrieta L, Erdmann H, Arnold-Schrauf C, Swallow M, Guderian M, Krull F, Hölscher A, Ghorbani P, Behrends J, Abraham WR, Hölscher C, Sparwasser TD, Berod L.

Front Immunol. 2018 Apr 5;9:495. doi: 10.3389/fimmu.2018.00495. eCollection 2018.

10.

Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways.

Ferreira GB, Vanherwegen AS, Eelen G, Gutiérrez ACF, Van Lommel L, Marchal K, Verlinden L, Verstuyf A, Nogueira T, Georgiadou M, Schuit F, Eizirik DL, Gysemans C, Carmeliet P, Overbergh L, Mathieu C.

Cell Rep. 2015 Feb 10;10(5):711-725. doi: 10.1016/j.celrep.2015.01.013. Epub 2015 Feb 7.

11.

HIF-1α-induced miR-23a∼27a∼24 cluster promotes colorectal cancer progression via reprogramming metabolism.

Jin F, Yang R, Wei Y, Wang D, Zhu Y, Wang X, Lu Y, Wang Y, Zen K, Li L.

Cancer Lett. 2019 Jan;440-441:211-222. doi: 10.1016/j.canlet.2018.10.025. Epub 2018 Oct 26.

PMID:
30393198
12.

miR-23b-3p suppressing PGC1α promotes proliferation through reprogramming metabolism in osteosarcoma.

Zhu R, Li X, Ma Y.

Cell Death Dis. 2019 May 16;10(6):381. doi: 10.1038/s41419-019-1614-1.

13.

Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation.

Johnson AR, Qin Y, Cozzo AJ, Freemerman AJ, Huang MJ, Zhao L, Sampey BP, Milner JJ, Beck MA, Damania B, Rashid N, Galanko JA, Lee DP, Edin ML, Zeldin DC, Fueger PT, Dietz B, Stahl A, Wu Y, Mohlke KL, Makowski L.

Mol Metab. 2016 Apr 23;5(7):506-526. doi: 10.1016/j.molmet.2016.04.005. eCollection 2016 Jul.

14.

Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.

Valentino A, Calarco A, Di Salle A, Finicelli M, Crispi S, Calogero RA, Riccardo F, Sciarra A, Gentilucci A, Galderisi U, Margarucci S, Peluso G.

Oncogene. 2017 Oct 26;36(43):6030-6040. doi: 10.1038/onc.2017.216. Epub 2017 Jul 3.

PMID:
28671672
15.

Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.

Jia D, Lu M, Jung KH, Park JH, Yu L, Onuchic JN, Kaipparettu BA, Levine H.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3909-3918. doi: 10.1073/pnas.1816391116. Epub 2019 Feb 7.

PMID:
30733294
16.

Role of the p38 MAPK/C/EBPβ Pathway in the Regulation of Phenotype and IL-10 and IL-12 Production by Tolerogenic Bone Marrow-Derived Dendritic Cells.

Guindi C, Cloutier A, Gaudreau S, Zerif E, McDonald PP, Tatsiy O, Asselin C, Dupuis G, Gris D, Amrani AA.

Cells. 2018 Dec 7;7(12). pii: E256. doi: 10.3390/cells7120256.

17.

Similarities in the Metabolic Reprogramming of Immune System and Endothelium.

Tang CY, Mauro C.

Front Immunol. 2017 Jul 21;8:837. doi: 10.3389/fimmu.2017.00837. eCollection 2017. Review.

18.

Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis.

Cha Y, Han MJ, Cha HJ, Zoldan J, Burkart A, Jung JH, Jang Y, Kim CH, Jeong HC, Kim BG, Langer R, Kahn CR, Guarente L, Kim KS.

Nat Cell Biol. 2017 May;19(5):445-456. doi: 10.1038/ncb3517. Epub 2017 Apr 24.

19.

The emerging role of ASC in dendritic cell metabolism during Chlamydia infection.

McKeithen DN, Omosun YO, Ryans K, Mu J, Xie Z, Simoneaux T, Blas-Machado U, Eko FO, Black CM, Igietseme JU, He Q.

PLoS One. 2017 Dec 7;12(12):e0188643. doi: 10.1371/journal.pone.0188643. eCollection 2017.

20.

The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.

Jin F, Wang Y, Zhu Y, Li S, Liu Y, Chen C, Wang X, Zen K, Li L.

Sci Rep. 2017 Jun 8;7(1):3089. doi: 10.1038/s41598-017-03407-3.

Supplemental Content

Support Center